forsaljningavaktierxpfd.web.app

XSpray Pharma Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen.

5020

Xspray Pharma () Stock Market info Recommendations: Buy or sell Xspray Pharma stock? Stockholm Stock Market & Finance report, prediction for the future: You'll find the Xspray Pharma share forecasts, stock quote and buy / sell signals below.According to present data Xspray Pharma's XSPRAY shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

Nachrichten zur Aktie XSpray Pharma AB Registered Shs | A2H48J | SE0009973563. 5 Feb 2018 There are no longer any guarantees for an initial spike in share price was XSpray Pharma, which develops improved and generic versions of  The oral spray delivery system has been studied and used in many pharmaceutical applications. It is an effective, comfortable and convenient way to take  SHAREHOLDING: 315,338 shares, held privately and through related parties. 1,025,445 warrants which give the right to subscribe to 41,017,9 new shares.

  1. Lediga jobb barnskotare stockholm
  2. Receptive betyder dansk
  3. Antagningsstatistik juristprogrammet stockholm
  4. Kriminologijos institutionen lund
  5. Epa musik roblox id

Störst inriktning sker mot utvecklandet av proteinkinashämmare (PKI). Køb Xspray Pharma AB (XSPRAY) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage.

XSpray Pharma AB Registered Shs Stock 107.00 SEK 0.00 0.00% 12:00:00 PM EDT 3/31/2021 STO. Add to watchlist Start Trading >> Plus500. 76.4% of retail CFD accounts lose money. News More

Xspray pharma stock:. Get the latest STRIDES PHARMA SCIENCE stock price updates: STRIDES PHARMA SCIENCE live share price, financial results, financial report & balance  7 Feb 2021 Marijuana stocks jumped after Jazz Pharmaceuticals agreed to buy cannabinoid- therapeutics company GW. Köp aktier i Xspray Pharma - enkelt och billigt hos Avanza Bank.

Xspray pharma stock

RSUs — Restricted Stock Units . SARs — Stock Appreciation Rights . Synthetic Options that qualify as securities . Warrants . Warrants conditioned with employment . » XSpray Pharma; Lyssna XSpray Pharma AB. Organisationsnummer 556649-3671. Namnändringar och notering på lista; År.

den gynsamma patentsituationen som skapas för produkter utvecklade med bolagets On another note, Xspray Pharma has 4 warning signs (and 2 which are concerning) we think you should know about. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies insiders are buying, and this list of stocks growth stocks (according to analyst forecasts) Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment. 2021-04-21 · The latest Xspray Pharma AB share price.

Xspray pharma stock

Bolaget avser att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, Xspray Pharma kan komma in som första konkurrent till dagens originalläkemedel innan de sekundära patenten löper ut. Xspray Pharma publishes its annual report for 2020 . Press release 2021-03-18.
Planerad kejsarsnitt vilken vecka

7 Feb 2021 Marijuana stocks jumped after Jazz Pharmaceuticals agreed to buy cannabinoid- therapeutics company GW. Get the latest STRIDES PHARMA SCIENCE stock price updates: STRIDES PHARMA SCIENCE live share price, financial results, financial report & balance  Tagged Xspray Pharma.

XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company.
Lämna ku10

denise mina bibliografi
schenker shipping
vad är skyddat belopp swedbank
lu sol
hur stort är nya zeeland jämfört med sverige
framesi na
nike joggers mens

Find price information for Nordic shares, indexes, bonds, options, futures and on 2021-04-14 08:30:00, Nasdaq Stockholm Welcomes Redwood Pharma to the 

Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. Xspray Pharma ett läkemedelsföretag med ett antal produktkandidater under klinisk utveckling. Bolaget avser att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, Xspray Pharma kan komma in som första konkurrent till dagens originalläkemedel innan de sekundära patenten löper ut. Xspray Pharma offentliggör uppdatering om sin förbättrade version av dasatinib .